A focused portfolio including placental-derived amniotic membranes and collagen-based wound matrices designed for consistency, reproducibility, and integration into hospital clinical programs.

A dual-layer placental-derived amniotic membrane matrix designed to provide enhanced structural integrity and predictable handling for institutional clinical use.
A single-layer placental-derived amniotic membrane matrix offering a foundational configuration for broad clinical applicability within hospital settings.
A collagen-based wound matrix powder designed to support wound management across a range of clinical environments.
All Arvix products share common quality systems, regulatory positioning, and documentation standards designed to simplify hospital evaluation and procurement.
Standardized processing across all products with documented quality controls and release testing.
Single regulatory framework and documentation package covering the entire product portfolio.
Complete donor-to-distribution tracking with documented chain of custody and lot-specific records.
Dedicated support team providing education, documentation, and implementation assistance.
A dual-layer placental-derived amniotic membrane matrix designed to provide enhanced structural integrity and predictable handling for institutional clinical use.
A single-layer placental-derived amniotic membrane matrix offering a foundational configuration for broad clinical applicability within hospital settings.
A collagen-based wound matrix powder designed to support wound management across a range of clinical environments.
Request our comprehensive VAC packet with detailed product specifications, regulatory documentation, and clinical support materials.